Sernova Corp. (TSE:SVA – Get Free Report) hit a new 52-week low during trading on Wednesday . The company traded as low as C$0.18 and last traded at C$0.18, with a volume of 47943 shares traded. The stock had previously closed at C$0.19.
Sernova Stock Performance
The firm has a market cap of C$58.89 million, a price-to-earnings ratio of -1.69 and a beta of 1.35. The company has a quick ratio of 18.11, a current ratio of 0.32 and a debt-to-equity ratio of -4.40. The stock has a 50 day moving average of C$0.21 and a 200 day moving average of C$0.23.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Recommended Stories
- Five stocks we like better than Sernova
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- How to Short Nasdaq: An Easy-to-Follow Guide
- Why Energy Transfer Belongs on Your Watchlist
- Most Volatile Stocks, What Investors Need to Know
- Why Wayfair Stock May Be a Hidden Gem for Value Investors
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
